What does FluoroPharma Medical, Inc. do?

FluoroPharma Medical, Inc. (FPMI) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

What is FPMI's market cap?

FluoroPharma Medical, Inc. (FPMI) has a market capitalization of approximately $6,852, as of August 27, 2026, based on the most recent share price and shares outstanding.

Does FPMI pay a dividend?

No — FluoroPharma Medical, Inc. (FPMI) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.

FluoroPharma Medical, Inc. (FPMI) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

FPMI

FluoroPharma Medical, Inc.

OTC·Biotechnology · Healthcare

$0.00$0.00+0.00%

Market cap$6.85K·Aug 27 8:00 PM UTC

Price Chart

$0.00+$0.00 (+0.00%)today

−96.00%CAGR −47.51%

Select date range

FromTo

May 16, 2011Aug 28, 2021 → Aug 28, 2026· 5.0 yrsAug 28, 2026

Key Metrics

FPMI does not currently pay a dividend.

EarningsEarnings Tab

EPS (FWD)—

P/E Ratio (FWD)—

EPS Growth (1Y)—

EPS Growth (3Y)—

EPS Growth (5Y)—

Next Earnings DateNov 27

Last Report DateMar 31

Reported vs Estimate−$0.01

Earnings Surprise—

FinancialsFinancials Tab

Revenue$0.00

Net Income−$2.05M

Net Margin—

Operating Cash Flow−$880.12K

Capital Expenditures$1.29

Free Cash Flow−$880.12K

Return on Equity—

Return on Invested Capital7.0%

Net Debt$5.80M

Value Graph

PRO

See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.

Click below to see what's inside, then upgrade to unlock for FPMI and 80,000+ other tickers.

EPS · Price vs. Fair Value Price Fair

Income Statement Flow

PRO

See exactly how FPMI's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for FPMI and 80,000+ other tickers.

About FluoroPharma Medical, Inc.

FluoroPharma Medical, Inc. (FPMI) is a biopharmaceutical firm dedicated to the discovery, development, and commercialization of advanced molecular imaging agents. Initially, its efforts are concentrated on cardiovascular applications within the United States market. The company's pipeline features two notable product candidates: BFPET: An imaging agent designed for stress-testing patients with suspected or confirmed coronary artery disease (CAD), which has successfully completed its Phase I clinical trial. CardioPET: Another molecular imaging agent, currently undergoing a Phase IIa clinical…

CEO: Edward L. Lyons Jr.
Sector: Healthcare
Industry: Biotechnology
Exchange: OTC
Employees: 4
Website: www.fluoropharma.com

Peers

Sienna Biopharmaceuticals, Inc.

Cap

$3.1K

EVLO

Evelo Biosciences, Inc.

Cap

$1.9K

Latest News

News Tab

No recent news available.

Frequently Asked Questions About FPMI

What does FluoroPharma Medical, Inc. do?: FluoroPharma Medical, Inc. (FPMI) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.
What is FPMI's market cap?: FluoroPharma Medical, Inc. (FPMI) has a market capitalization of approximately $6,852, as of August 27, 2026, based on the most recent share price and shares outstanding.
Does FPMI pay a dividend?: No — FluoroPharma Medical, Inc. (FPMI) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.
Is FPMI profitable?: FluoroPharma Medical, Inc. (FPMI) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.